AN2 Therapeutics Inc (ANTX)
2.265
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
2.265
0.00 (0.00%)
After-Hours: 20:00
AN2 Therapeutics Price: 2.265 for May 17, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 17, 2024 | 2.28 | 2.32 | 2.25 | 2.27 | 57325.00 |
May 16, 2024 | 2.30 | 2.330 | 2.24 | 2.27 | 92758.00 |
May 15, 2024 | 2.34 | 2.41 | 2.21 | 2.27 | 241609.0 |
May 14, 2024 | 2.41 | 2.425 | 2.29 | 2.31 | 76766.00 |
May 13, 2024 | 2.43 | 2.44 | 2.35 | 2.35 | 92932.00 |
May 10, 2024 | 2.46 | 2.470 | 2.35 | 2.42 | 96022.00 |
May 09, 2024 | 2.43 | 2.47 | 2.41 | 2.47 | 60975.00 |
May 08, 2024 | 2.55 | 2.59 | 2.44 | 2.44 | 74564.00 |
May 07, 2024 | 2.61 | 2.64 | 2.54 | 2.55 | 91221.00 |
May 06, 2024 | 2.60 | 2.61 | 2.45 | 2.59 | 127992.0 |
May 03, 2024 | 2.56 | 2.67 | 2.50 | 2.56 | 168385.0 |
May 02, 2024 | 2.42 | 2.57 | 2.410 | 2.54 | 82302.00 |
May 01, 2024 | 2.40 | 2.49 | 2.377 | 2.40 | 58105.00 |
Apr 30, 2024 | 2.39 | 2.445 | 2.36 | 2.40 | 91402.00 |
Apr 29, 2024 | 2.34 | 2.44 | 2.34 | 2.37 | 67621.00 |
Apr 26, 2024 | 2.30 | 2.37 | 2.20 | 2.32 | 121380.0 |
Apr 25, 2024 | 2.39 | 2.40 | 2.28 | 2.28 | 178962.0 |
Apr 24, 2024 | 2.39 | 2.44 | 2.39 | 2.40 | 44748.00 |
Apr 23, 2024 | 2.36 | 2.42 | 2.31 | 2.37 | 83086.00 |
Apr 22, 2024 | 2.49 | 2.496 | 2.36 | 2.36 | 116269.0 |
Apr 19, 2024 | 2.48 | 2.48 | 2.40 | 2.47 | 101636.0 |
Apr 18, 2024 | 2.48 | 2.52 | 2.36 | 2.38 | 145364.0 |
Apr 17, 2024 | 2.48 | 2.508 | 2.43 | 2.48 | 87478.00 |
Apr 16, 2024 | 2.51 | 2.55 | 2.43 | 2.47 | 72705.00 |
Apr 15, 2024 | 2.74 | 2.74 | 2.50 | 2.50 | 192659.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.265
Minimum
May 17 2024
22.29
Maximum
Aug 15 2022
11.38
Average
10.39
Median
Price Benchmarks
Revance Therapeutics Inc | 3.025 |
Viking Therapeutics Inc | 67.00 |
VYNE Therapeutics Inc | 2.79 |
Aquestive Therapeutics Inc | 3.10 |
Humacyte Inc | 6.33 |
Price Related Metrics
Price to Book Value | 0.6122 |
Earnings Yield | -114.1% |
Market Cap | 67.71M |